Mishra, H. K., Wei, H., Rohr, K. E., Ko, I., Nievergelt, C. M., Maihofer, A. X., Shilling, P. D., Alda, M., Berrettini, W. H., Brennand, K. J., Calabrese, J. R., Coryell, W. H., Frye, M., Gage, F., Gershon, E., McInnis, M. G., Nurnberger, J., Oedegaard, K. J., Zandi, P. P., ... McCarthy, M. J. (2023). Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder. European Neuropsychopharmacology, 74, 1-14. https://doi.org/10.1016/j.euroneuro.2023.04.009
Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder. / Mishra, Himanshu K.; Wei, Heather; Rohr, Kayla E. 等.
在:
European Neuropsychopharmacology, 卷 74, 09.2023, 页码 1-14.
科研成果: 期刊稿件 › 文章 › 同行评审
Mishra, HK, Wei, H, Rohr, KE, Ko, I, Nievergelt, CM, Maihofer, AX, Shilling, PD, Alda, M, Berrettini, WH, Brennand, KJ, Calabrese, JR, Coryell, WH, Frye, M, Gage, F, Gershon, E, McInnis, MG, Nurnberger, J, Oedegaard, KJ, Zandi, PP, Kelsoe, JR & McCarthy, MJ 2023, 'Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder', European Neuropsychopharmacology, 卷 74, 页码 1-14. https://doi.org/10.1016/j.euroneuro.2023.04.009
Mishra HK, Wei H, Rohr KE, Ko I, Nievergelt CM, Maihofer AX 等. Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder. European Neuropsychopharmacology. 2023 9月;74:1-14. doi: 10.1016/j.euroneuro.2023.04.009
Mishra, Himanshu K. ; Wei, Heather ; Rohr, Kayla E. 等. / Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder. 在: European Neuropsychopharmacology. 2023 ; 卷 74. 页码 1-14.
@article{17594a12a3374b03a6c9ebeadb9e9aa1,
title = "Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder",
author = "Mishra, {Himanshu K.} and Heather Wei and Rohr, {Kayla E.} and Insu Ko and Nievergelt, {Caroline M.} and Maihofer, {Adam X.} and Shilling, {Paul D.} and Martin Alda and Berrettini, {Wade H.} and Brennand, {Kristen J.} and Calabrese, {Joseph R.} and Coryell, {William H.} and Mark Frye and Fred Gage and Elliot Gershon and McInnis, {Melvin G.} and John Nurnberger and Oedegaard, {Ketil J.} and Zandi, {Peter P.} and Kelsoe, {John R.} and McCarthy, {Michael J.}",
note = "Funding Information: The work was funded by VA Merit Awards to MJM (BX003431) and a Catalyst Research Award from the International Bipolar Foundation to MJM. Sample collection and clinical assessment in the PGBD Trial was supported by NIMH/NIGMS (MH92758), The Western Norway Regional Health Authority and the Canadian Institutes of Health Research (#64410). The funders had no influence on the interpretation of the results or the decision to publish. Publisher Copyright: {\textcopyright} 2023",
year = "2023",
month = sep,
doi = "10.1016/j.euroneuro.2023.04.009",
language = "English",
volume = "74",
pages = "1--14",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
}
TY - JOUR
T1 - Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder
AU - Mishra, Himanshu K.
AU - Wei, Heather
AU - Rohr, Kayla E.
AU - Ko, Insu
AU - Nievergelt, Caroline M.
AU - Maihofer, Adam X.
AU - Shilling, Paul D.
AU - Alda, Martin
AU - Berrettini, Wade H.
AU - Brennand, Kristen J.
AU - Calabrese, Joseph R.
AU - Coryell, William H.
AU - Frye, Mark
AU - Gage, Fred
AU - Gershon, Elliot
AU - McInnis, Melvin G.
AU - Nurnberger, John
AU - Oedegaard, Ketil J.
AU - Zandi, Peter P.
AU - Kelsoe, John R.
AU - McCarthy, Michael J.
N1 - Funding Information:
The work was funded by VA Merit Awards to MJM (BX003431) and a Catalyst Research Award from the International Bipolar Foundation to MJM. Sample collection and clinical assessment in the PGBD Trial was supported by NIMH/NIGMS (MH92758), The Western Norway Regional Health Authority and the Canadian Institutes of Health Research (#64410). The funders had no influence on the interpretation of the results or the decision to publish.
Publisher Copyright:
© 2023
PY - 2023/9
Y1 - 2023/9
UR - http://www.scopus.com/inward/record.url?scp=85153796976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85153796976&partnerID=8YFLogxK
U2 - 10.1016/j.euroneuro.2023.04.009
DO - 10.1016/j.euroneuro.2023.04.009
M3 - Article
AN - SCOPUS:85153796976
SN - 0924-977X
VL - 74
SP - 1
EP - 14
JO - European Neuropsychopharmacology
JF - European Neuropsychopharmacology
ER -